FDA-authorized AI medical devices remain heavily concentrated in a handful of specialties despite rapid growth in the number of authorizations, according to a new analysis.
Growing reliance on vendors, remote access, and connected technologies is expanding healthcare’s cyber risk and putting greater emphasis on third-party oversight and continuity planning.
Three new Vivid systems target different cardiovascular imaging settings and have received CE Mark, with US FDA clearance pending.
FDA-authorized AI medical devices remain heavily concentrated in a handful of specialties despite rapid growth in the number of authorizations, according to a new analysis.
Malicious attacks using artificial intelligence increased 56% over the previous year, according to the 2026 Cost of a Data Breach Report.
Read More
The health system is the first in the US to commercially use the technology to help surgeons identify microscopic cancer in real-time.
Read More
The work group will develop playbooks and risk assessment tools to help healthcare organizations defend against advanced model risks.
Read More
The new platform features artificial intelligence specialists to automate risk detection and remediation for healthcare technology.
Read More
The company’s new positioning focuses on the integration of clinical engineering, cybersecurity, and data insights.
Read More
The new product family includes two compact systems designed for use in various clinical applications and care settings.
Read More
The system uses real-time data to support clinical decision-making and includes an FDA-cleared application for monitoring surgical instruments.
